KA
Kala Pharma
KALA·NASDAQWaltham MAFounded 2009120 employees
Micro CapbiotechPublicOphthalmology
Platform: AMPPLIFY Ophth
Market Cap
$0.04B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (KALA)
Loading KALA stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| KAL-3067 | KAL-3067 | Phase 2/3 | 1 | JAK2 | TTR Amyloidosis | ||
| KAL-3824 | KAL-3824 | Phase 1/2 | 2 | FLT3 | ASNASH |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (2)